SG Americas Securities LLC Has $3.72 Million Stock Position in Scholar Rock Holding Corporation $SRRK

SG Americas Securities LLC raised its stake in Scholar Rock Holding Corporation (NASDAQ:SRRK) by 602.4% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 84,349 shares of the company’s stock after buying an additional 72,341 shares during the quarter. SG Americas Securities LLC owned about 0.08% of Scholar Rock worth $3,716,000 at the end of the most recent reporting period.

Several other large investors also recently made changes to their positions in SRRK. Principal Financial Group Inc. raised its holdings in shares of Scholar Rock by 7.9% during the third quarter. Principal Financial Group Inc. now owns 6,214 shares of the company’s stock worth $231,000 after acquiring an additional 456 shares during the period. California State Teachers Retirement System boosted its stake in Scholar Rock by 0.9% in the 2nd quarter. California State Teachers Retirement System now owns 62,372 shares of the company’s stock worth $2,209,000 after purchasing an additional 577 shares during the period. E Fund Management Co. Ltd. increased its holdings in Scholar Rock by 6.8% during the 2nd quarter. E Fund Management Co. Ltd. now owns 11,146 shares of the company’s stock worth $395,000 after purchasing an additional 710 shares in the last quarter. AlphaQuest LLC increased its holdings in Scholar Rock by 30.1% during the 3rd quarter. AlphaQuest LLC now owns 3,415 shares of the company’s stock worth $127,000 after purchasing an additional 791 shares in the last quarter. Finally, Ramirez Asset Management Inc. acquired a new stake in shares of Scholar Rock in the 3rd quarter valued at about $37,000. Institutional investors own 91.08% of the company’s stock.

Wall Street Analyst Weigh In

Several research analysts have recently weighed in on the company. Wedbush upped their price objective on Scholar Rock from $56.00 to $58.00 and gave the stock an “outperform” rating in a research report on Wednesday. Citigroup lifted their target price on Scholar Rock from $55.00 to $58.00 and gave the company a “buy” rating in a research report on Wednesday, March 4th. Barclays boosted their target price on Scholar Rock from $52.00 to $53.00 and gave the company an “overweight” rating in a research note on Tuesday, March 3rd. BMO Capital Markets raised their price target on shares of Scholar Rock from $50.00 to $70.00 and gave the stock an “outperform” rating in a research note on Wednesday, March 4th. Finally, JPMorgan Chase & Co. lifted their price objective on shares of Scholar Rock from $47.00 to $50.00 and gave the company an “overweight” rating in a report on Monday, March 16th. Four investment analysts have rated the stock with a Strong Buy rating, twelve have assigned a Buy rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the stock has an average rating of “Buy” and a consensus target price of $54.93.

Insider Activity

In related news, insider Mo Qatanani sold 14,898 shares of the firm’s stock in a transaction on Thursday, January 22nd. The shares were sold at an average price of $46.71, for a total value of $695,885.58. Following the completion of the transaction, the insider directly owned 85,660 shares of the company’s stock, valued at approximately $4,001,178.60. This trade represents a 14.82% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO David Hallal sold 57,450 shares of the business’s stock in a transaction on Tuesday, January 13th. The stock was sold at an average price of $42.70, for a total transaction of $2,453,115.00. Following the transaction, the chief executive officer owned 1,541,645 shares in the company, valued at approximately $65,828,241.50. The trade was a 3.59% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders have sold 207,464 shares of company stock worth $9,157,423. Corporate insiders own 13.30% of the company’s stock.

Scholar Rock Price Performance

Shares of NASDAQ SRRK opened at $50.01 on Friday. The company has a debt-to-equity ratio of 0.41, a current ratio of 6.95 and a quick ratio of 6.95. The business has a 50-day moving average of $45.22 and a 200-day moving average of $40.75. The stock has a market capitalization of $5.75 billion, a price-to-earnings ratio of -14.58 and a beta of 0.68. Scholar Rock Holding Corporation has a fifty-two week low of $22.71 and a fifty-two week high of $50.50.

Scholar Rock (NASDAQ:SRRK) last released its earnings results on Tuesday, March 3rd. The company reported ($0.76) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.86) by $0.10. During the same period in the prior year, the business posted ($0.64) EPS. As a group, sell-side analysts predict that Scholar Rock Holding Corporation will post -2.42 earnings per share for the current fiscal year.

Scholar Rock Company Profile

Scholar Rock is a clinical-stage biotechnology company focused on the discovery and development of protein therapeutics that selectively target growth factors involved in disease processes. The company’s research platform is designed to modulate endogenous growth factor activation and signaling with high specificity, aiming to restore normal biological function across a range of disorders. Scholar Rock’s approach is distinguished by its emphasis on engineering antibodies and biologics that interact with growth factor precursors or latent complexes rather than the active form, potentially offering improved safety and efficacy profiles.

The company’s lead program, SRK-015 (appercept), is an investigational monoclonal antibody targeting the activation of latent myostatin proproteins and is being evaluated for the treatment of spinal muscular atrophy (SMA).